Log in to save to my catalogue

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐t...

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐t...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e91b779634644a49a0e1fdf6e4742a9

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study

About this item

Full title

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study

Publisher

Germany: John Wiley & Sons, Inc

Journal title

Journal of cachexia, sarcopenia and muscle, 2021-12, Vol.12 (6), p.1501-1512

Language

English

Formats

Publication information

Publisher

Germany: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Pulmonary arterial hypertension (PAH) is a progressive disease with limited survival. Iron deficiency (ID) correlates with disease severity and mortality. While oral iron supplementation was shown to be insufficient in such patients, the potential impact of parenteral iron on clinical measures warrants further investigation.
Method...

Alternative Titles

Full title

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4e91b779634644a49a0e1fdf6e4742a9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e91b779634644a49a0e1fdf6e4742a9

Other Identifiers

ISSN

2190-5991

E-ISSN

2190-6009

DOI

10.1002/jcsm.12764

How to access this item